|
GB806876A
(en)
|
1956-02-16 |
1959-01-07 |
Wellcome Found |
Improvements in and relating to disposable hypodermic injection devices
|
|
GB873526A
(en)
|
1957-08-14 |
1961-07-26 |
Upjohn Co |
Fluid compositions comprising (acetyl-salicylic acid)-anhydride
|
|
GB887872A
(en)
|
1958-06-25 |
1962-01-24 |
Upjohn Co |
Improvements in or relating to pharmaceutical preparations
|
|
DE1467938C3
(de)
|
1964-05-22 |
1973-12-20 |
F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) |
Wasserdispergierbares Arzneipräparat für Tiere
|
|
JPS5078634A
(enExample)
|
1973-11-16 |
1975-06-26 |
|
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4906474A
(en)
|
1983-03-22 |
1990-03-06 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
|
US4725442A
(en)
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
|
US4622219A
(en)
|
1983-06-17 |
1986-11-11 |
Haynes Duncan H |
Method of inducing local anesthesia using microdroplets of a general anesthetic
|
|
US4891225A
(en)
|
1984-05-21 |
1990-01-02 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
|
US4588580B2
(en)
|
1984-07-23 |
1999-02-16 |
Alaz Corp |
Transdermal administration of fentanyl and device therefor
|
|
US4534974A
(en)
|
1984-07-31 |
1985-08-13 |
Carter-Wallace, Inc. |
Pharmaceutical compositions with codeine
|
|
US4626539A
(en)
|
1984-08-10 |
1986-12-02 |
E. I. Dupont De Nemours And Company |
Trandermal delivery of opioids
|
|
US4573995A
(en)
|
1984-10-09 |
1986-03-04 |
Alza Corporation |
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
|
|
US4804663A
(en)
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
|
GB8522453D0
(en)
|
1985-09-11 |
1985-10-16 |
Lilly Industries Ltd |
Chewable capsules
|
|
JPS62298530A
(ja)
|
1986-06-16 |
1987-12-25 |
Otsuka Pharmaceut Co Ltd |
坐薬用医薬組成物
|
|
IT1198449B
(it)
|
1986-10-13 |
1988-12-21 |
F I D I Farmaceutici Italiani |
Esteri di alcoli polivalenti di acido ialuronico
|
|
US5702716A
(en)
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
US4938763B1
(en)
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
|
US5008110A
(en)
|
1988-11-10 |
1991-04-16 |
The Procter & Gamble Company |
Storage-stable transdermal patch
|
|
CA2002299A1
(en)
|
1988-11-10 |
1990-05-10 |
Eugene G. Drust |
Compositions for the transdermal delivery of buprenorphine salts
|
|
US5026556A
(en)
|
1988-11-10 |
1991-06-25 |
Norwich Eaton Pharmaceuticals, Inc. |
Compositions for the transdermal delivery of pharmaceutical actives
|
|
US5324519A
(en)
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
US5487897A
(en)
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
|
DE3927113C2
(de)
|
1989-08-17 |
1993-11-25 |
Dolorgiet Gmbh & Co Kg |
Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
|
|
US5096715A
(en)
|
1989-11-20 |
1992-03-17 |
Alko Ltd. |
Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
|
|
US5558880A
(en)
|
1989-12-22 |
1996-09-24 |
Janssen Pharmaceutica Inc. |
Pharmaceutical and other dosage forms
|
|
US5660851A
(en)
|
1989-12-26 |
1997-08-26 |
Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem |
Ocular inserts
|
|
DK0532546T3
(da)
|
1990-05-10 |
1998-12-28 |
Nycomed Pharma As |
Farmaceutisk præparat indeholdende N-glycofuroler og N-ethylenglycoler
|
|
US5069909A
(en)
|
1990-06-20 |
1991-12-03 |
Cygnus Therapeutic Systems |
Transdermal administration of buprenorphine
|
|
JPH0456736U
(enExample)
|
1990-09-14 |
1992-05-15 |
|
|
|
US5149543A
(en)
|
1990-10-05 |
1992-09-22 |
Massachusetts Institute Of Technology |
Ionically cross-linked polymeric microcapsules
|
|
ATE183639T1
(de)
|
1991-02-18 |
1999-09-15 |
Commw Scient Ind Res Org |
Zusammensetzung zur verwendung in der transdermalen verabreichung
|
|
JP3145742B2
(ja)
|
1991-09-19 |
2001-03-12 |
日東電工株式会社 |
ゴム系感圧性接着剤とその接着シ―ト
|
|
AU2605592A
(en)
|
1991-10-15 |
1993-04-22 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
WO1993023019A1
(en)
|
1992-05-11 |
1993-11-25 |
Sri International |
Transdermal drug delivery systems and related compositions and methods of use
|
|
EP0669128B1
(en)
|
1992-11-17 |
2000-01-05 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained-release microsphere containing antipsychotic and process for producing the same
|
|
TW376319B
(en)
|
1993-04-28 |
1999-12-11 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
|
|
JP2651106B2
(ja)
|
1993-06-28 |
1997-09-10 |
大同鋼板株式会社 |
金属屋根材の葺設構造及びその葺設方法
|
|
NZ260909A
(en)
|
1993-07-05 |
1995-04-27 |
Takeda Chemical Industries Ltd |
Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
|
|
US5643605A
(en)
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
|
ATE288270T1
(de)
|
1993-11-19 |
2005-02-15 |
Janssen Pharmaceutica Nv |
Mikroverkapselte 1,2-benzazole
|
|
ATE212830T1
(de)
|
1993-11-19 |
2002-02-15 |
Alkermes Inc |
Herstellung biologisch abbaubarer, einen biologisch aktiven stoff enthaltender, mikropartikel
|
|
EP1125577B1
(en)
|
1994-04-08 |
2006-02-15 |
QLT USA, Inc. |
Liquid drug delivery compositions
|
|
US5453425A
(en)
|
1994-07-11 |
1995-09-26 |
Janssen Pharmaceutica N.V. |
Risperidone oral formulation
|
|
AU4652596A
(en)
|
1995-01-09 |
1996-07-31 |
Atrix Laboratories, Inc. |
Liquid polymer delivery system
|
|
JP3274579B2
(ja)
|
1995-01-12 |
2002-04-15 |
住友製薬株式会社 |
脳血管障害に伴う精神症候治療剤
|
|
EP1525858A1
(en)
|
1995-06-07 |
2005-04-27 |
Durect Corporation |
High viscosity liquid controlled delivery system
|
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5968542A
(en)
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
|
US6004969A
(en)
|
1996-04-15 |
1999-12-21 |
National Science Council |
Transdermal delivery of buprenorphine preparations
|
|
ES2183172T3
(es)
|
1996-05-07 |
2003-03-16 |
Alkermes Inc |
Procedimiento para la preparacion de microparticulas.
|
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
|
JP4346696B2
(ja)
|
1996-05-28 |
2009-10-21 |
久光製薬株式会社 |
経皮治療用装置
|
|
EP0910345B1
(en)
|
1996-06-17 |
2002-02-13 |
Janssen Pharmaceutica N.V. |
Biconvex rapidly disintegrating dosage forms
|
|
ATE318580T1
(de)
|
1996-12-20 |
2006-03-15 |
Alza Corp |
Gelzusammensetzungen und verfahren
|
|
DE19701912C1
(de)
|
1997-01-10 |
1998-05-14 |
Jenapharm Gmbh |
Injizierbares Implantat
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
IT1292396B1
(it)
|
1997-06-23 |
1999-02-08 |
Lisapharma Spa |
Cerotto dermico avente elevata resistenza meccanica,flessibilita' trasparenza e conducibilita' elettrica nel trattamento di affezioni
|
|
US6622036B1
(en)
|
2000-02-09 |
2003-09-16 |
Cns Response |
Method for classifying and treating physiologic brain imbalances using quantitative EEG
|
|
DE69916911T2
(de)
|
1998-02-10 |
2005-04-21 |
Gen Electric |
Brenner mit gleichmässiger Brennstoff/Luft Vormischung zur emissionsarmen Verbrennung
|
|
US6733767B2
(en)
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
|
US7208011B2
(en)
|
2001-08-20 |
2007-04-24 |
Conor Medsystems, Inc. |
Implantable medical device with drug filled holes
|
|
US6261583B1
(en)
|
1998-07-28 |
2001-07-17 |
Atrix Laboratories, Inc. |
Moldable solid delivery system
|
|
US6703047B2
(en)
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
|
US6565874B1
(en)
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
|
US6355657B1
(en)
|
1998-12-30 |
2002-03-12 |
Atrix Laboratories, Inc. |
System for percutaneous delivery of opioid analgesics
|
|
US6194006B1
(en)
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
|
DE19923551A1
(de)
|
1999-05-21 |
2000-11-30 |
Lohmann Therapie Syst Lts |
Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
|
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
DE50112157D1
(de)
|
2000-01-11 |
2007-04-19 |
Roland Bodmeier |
Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
|
|
KR100393478B1
(ko)
|
2000-03-29 |
2003-08-06 |
주식회사종근당 |
자가유화 매트릭스형 경점막·경피흡수제제
|
|
ATE264329T1
(de)
|
2000-05-05 |
2004-04-15 |
Rpg Life Sciences Ltd |
Verfahren zur herstellung von antipsychotischem 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-
|
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
JP2004511431A
(ja)
|
2000-06-28 |
2004-04-15 |
アトゥル・ジェイ・シュクラ |
生物活性物質を含む生分解性ビヒクルおよび送達システム
|
|
DE10035889A1
(de)
|
2000-07-24 |
2002-02-14 |
Lohmann Therapie Syst Lts |
Medizinischer Haftkleber mit einem Gehalt an Zucker-Estern
|
|
ATE401313T1
(de)
|
2000-08-14 |
2008-08-15 |
Teva Pharma |
Herstellung von risperidon
|
|
DE10044545A1
(de)
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
|
IT250575Y1
(it)
|
2000-10-10 |
2003-09-24 |
Gimatic Spa |
Sistema di guida registrabile per griffe di pinze azionate da unfluido
|
|
WO2002038185A2
(en)
|
2000-11-13 |
2002-05-16 |
Atrix Laboratories, Inc. |
Injectable sustained release delivery system with loperamide
|
|
EP1335704A2
(en)
|
2000-11-16 |
2003-08-20 |
Durect Corporation |
Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
|
|
DE60231862D1
(de)
|
2001-02-23 |
2009-05-20 |
Genentech Inc |
Erodierbare polymere zur injektion
|
|
US20040018238A1
(en)
|
2001-02-26 |
2004-01-29 |
Shukla Atul J |
Biodegradable vehicles and delivery systems of biolgically active substances
|
|
WO2002076344A1
(en)
|
2001-03-23 |
2002-10-03 |
Durect Corporation |
Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
|
|
US6558702B2
(en)
*
|
2001-04-13 |
2003-05-06 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
|
GB0112324D0
(en)
|
2001-05-21 |
2001-07-11 |
Croda Int Plc |
Compounds
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
JP2003063954A
(ja)
|
2001-08-24 |
2003-03-05 |
Saitama Daiichi Seiyaku Kk |
リザーバー型貼付剤
|
|
ATE507816T1
(de)
|
2001-11-14 |
2011-05-15 |
Durect Corp |
Injizierbare depotzusammensetzungen und deren verwendung
|
|
NZ533434A
(en)
|
2001-11-14 |
2006-11-30 |
Alza Corp |
Thixotropic gel composition for injectable deposition
|
|
AU2002359407B2
(en)
|
2001-11-14 |
2008-02-28 |
Durect Corporation |
Catheter injectable depot compositions and uses thereof
|
|
US20040258731A1
(en)
|
2001-11-21 |
2004-12-23 |
Tsuyoshi Shimoboji |
Preparation approriate for cartilage tissue formation
|
|
NZ535270A
(en)
|
2002-03-12 |
2006-11-30 |
Univ Montreal |
Composition having gelling properties for the sustained delivery of bioactive substances
|
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
|
TWI314464B
(en)
|
2002-06-24 |
2009-09-11 |
Alza Corp |
Reusable, spring driven autoinjector
|
|
TWI353854B
(en)
|
2002-06-25 |
2011-12-11 |
Alza Corp |
Short duration depot formulations
|
|
US20040003401A1
(en)
|
2002-06-27 |
2004-01-01 |
Koninklijke Philips Electronics N.V. |
Method and apparatus for using cluster compactness as a measure for generation of additional clusters for stereotyping programs
|
|
CN1684663A
(zh)
|
2002-07-31 |
2005-10-19 |
阿尔萨公司 |
可注射的多模式聚合物储库组合物以及其用途
|
|
AU2003257994A1
(en)
|
2002-07-31 |
2004-02-16 |
Alza Corporation |
Injection device providing automatic needle retraction
|
|
AU2003256006A1
(en)
|
2002-08-30 |
2004-03-19 |
Sunil Sadanand Nadkarni |
Improved process for preparation of risperidone
|
|
CA2500908A1
(en)
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
|
KR20040034996A
(ko)
|
2002-10-18 |
2004-04-29 |
한미약품 주식회사 |
리스페리돈의 개선된 제조방법
|
|
EP1575616A2
(en)
|
2002-10-25 |
2005-09-21 |
Pfizer Products Inc. |
Novel injectable depot formulations
|
|
DE10250084A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US7368126B2
(en)
|
2002-11-06 |
2008-05-06 |
Guohua Chen |
Controlled release depot formulations
|
|
EP2218448B1
(en)
|
2002-12-13 |
2015-09-23 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
|
WO2004071491A1
(en)
|
2003-02-04 |
2004-08-26 |
Chrysalis Technologies Incorporated |
Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem
|
|
US8877241B2
(en)
|
2003-03-26 |
2014-11-04 |
Egalet Ltd. |
Morphine controlled release system
|
|
WO2004094415A1
(en)
|
2003-04-22 |
2004-11-04 |
Synthon B.V. |
Risperidone monohydrochloride
|
|
US20050079202A1
(en)
|
2003-05-30 |
2005-04-14 |
Guohua Chen |
Implantable elastomeric depot compositions and uses thereof
|
|
ATE410186T1
(de)
|
2003-06-26 |
2008-10-15 |
Control Delivery Sys Inc |
In-situ gelierendes arzneimittelabgabesystem
|
|
TWI357815B
(en)
|
2003-06-27 |
2012-02-11 |
Euro Celtique Sa |
Multiparticulates
|
|
FI20045223L
(fi)
|
2004-06-15 |
2005-12-16 |
Bioretec Oy |
Monitoiminen biohajoava komposiitti ja kirurginen implantti, joka käsittää mainitun komposiitin
|
|
US20050032781A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Elliot Ehrich |
Methods for administering active agents to CYP 2D6 sensitive patients
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
WO2005021046A1
(en)
|
2003-09-01 |
2005-03-10 |
Fh Faulding & Co Ltd |
Compositions and methods for delivery of biologically active agents
|
|
WO2005037949A2
(en)
|
2003-10-07 |
2005-04-28 |
Chrysalis Technologies Incorporated |
Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine
|
|
US20070191815A1
(en)
|
2004-09-13 |
2007-08-16 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
US20050281879A1
(en)
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US20050106214A1
(en)
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
EP1689465A4
(en)
|
2003-12-05 |
2011-10-12 |
Zogenix Inc |
DEVICE FOR DELIVERY OF A NEEDLELESS INJECTOR USED FOR DRUG DELIVERY
|
|
CA2552241C
(en)
|
2003-12-30 |
2013-10-01 |
Durect Corporation |
Co-polymeric devices for controlled release of active agents
|
|
US8329203B2
(en)
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
KR101242486B1
(ko)
|
2004-01-12 |
2013-03-13 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
장기 전달을 위한 제형 및 그의 이용 방법
|
|
WO2005089670A1
(en)
|
2004-03-15 |
2005-09-29 |
Durect Corporation |
Pharmaceutical compositions for administration to a sinus
|
|
IS7290A
(is)
|
2004-05-28 |
2005-11-29 |
Actavis Group |
Lyfjasamsetningar sem innihalda risperidone
|
|
PL1768650T3
(pl)
|
2004-06-04 |
2009-01-30 |
Camurus Ab |
Ciekłe formulacje depot
|
|
EP1604693A1
(en)
|
2004-06-09 |
2005-12-14 |
Scil Technology GmbH |
In situ forming scaffold, its manufacturing and use
|
|
GB2418854B
(en)
|
2004-08-31 |
2009-12-23 |
Euro Celtique Sa |
Multiparticulates
|
|
CA2582374A1
(en)
|
2004-10-04 |
2006-04-20 |
Qlt Usa, Inc. |
Ocular delivery of polymeric delivery formulations
|
|
US8313763B2
(en)
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
ATE551995T1
(de)
|
2004-10-21 |
2012-04-15 |
Durect Corp |
Transdermale abgabesysteme
|
|
EP1824460B1
(en)
|
2004-11-10 |
2014-12-24 |
Tolmar Therapeutics, Inc. |
A stabilized polymeric delivery system
|
|
GB2420976B
(en)
|
2004-11-19 |
2006-12-20 |
Zvi Finkelstein |
Therapeutic implant
|
|
AR052155A1
(es)
|
2004-12-14 |
2007-03-07 |
Novartis Ag |
Compuestos organicos
|
|
WO2006065951A2
(en)
|
2004-12-15 |
2006-06-22 |
Qlt Usa, Inc. |
Sustained delivery formulations of octreotide compounds
|
|
WO2006063430A1
(en)
|
2004-12-16 |
2006-06-22 |
Miv Therapeutics Inc. |
Multi-layer drug delivery device and method of manufacturing same
|
|
US9415034B2
(en)
|
2005-01-05 |
2016-08-16 |
National Defense Medical Center |
Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
|
|
US9168216B2
(en)
|
2005-06-17 |
2015-10-27 |
Vital Health Sciences Pty. Ltd. |
Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
|
|
JP5405825B2
(ja)
|
2005-07-18 |
2014-02-05 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
薬剤含有インプラント及びその使用方法
|
|
US20070020186A1
(en)
|
2005-07-22 |
2007-01-25 |
Alpex Pharma S.A. |
Solid dosage formulations of narcotic drugs having improved buccal adsorption
|
|
WO2007017712A1
(en)
|
2005-08-11 |
2007-02-15 |
Promedon Do Brasil Produtos Medico-Hospitalares Ltda. |
Composition comprising polymeric, water-insoluble, anionic particles, processes and uses
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
JP5406530B2
(ja)
|
2005-10-26 |
2014-02-05 |
バナー ファーマキャプス， インコーポレイテッド |
親水性ベヒクルに基づく二重制御された放出マトリクスシステム
|
|
CA2637569C
(en)
|
2006-01-18 |
2013-01-08 |
Yuhua Li |
Pharmaceutical compositions with enhanced stability
|
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US8765178B2
(en)
|
2006-07-19 |
2014-07-01 |
Watson Laboratories, Inc. |
Controlled release formulations and associated methods
|
|
ATE492192T1
(de)
|
2006-09-25 |
2011-01-15 |
Koninkl Philips Electronics Nv |
Heisswasserkessel mit einem akustischen element zur erzeugung eines akustischen signals
|
|
HUE038022T4
(hu)
|
2006-10-02 |
2023-02-28 |
Spepharm Ag |
Nem mukoadhezív filmdózisformák
|
|
US20100098735A1
(en)
|
2006-10-05 |
2010-04-22 |
Rajesh Jain |
Injectable depot compositions and its process of preparation
|
|
EP2079767B1
(en)
*
|
2006-10-11 |
2014-08-27 |
Tolmar Therapeutics, Inc. |
Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
|
|
US8076448B2
(en)
|
2006-10-11 |
2011-12-13 |
Tolmar Therapeutics, Inc. |
Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
|
|
GB0620661D0
(en)
|
2006-10-18 |
2006-11-29 |
Pharmasol Ltd |
Novel compounds
|
|
EP3202814B1
(en)
|
2007-02-15 |
2019-10-16 |
Tolmar Therapeutics, Inc. |
Low burst poly-(lactide/glycolide) and methods to produce polymers
|
|
KR101612901B1
(ko)
|
2007-03-02 |
2016-04-15 |
테이카 세이야쿠 가부시키가이샤 |
경피흡수 의약조성물, 의약조성물 저장유닛 및 이것을 이용하는 경피흡수제제
|
|
CN101678125A
(zh)
|
2007-04-03 |
2010-03-24 |
特里梅里斯公司 |
用于递送抗病毒肽治疗剂的新制剂
|
|
CN101677952B
(zh)
|
2007-05-18 |
2012-12-05 |
杜雷科特公司 |
改进的贮库制剂
|
|
EP2152315B1
(en)
*
|
2007-05-25 |
2016-01-06 |
Indivior UK Limited |
Sustained delivery formulations of risperidone compounds
|
|
HUE027537T2
(en)
|
2007-09-03 |
2016-10-28 |
Nanotherapeutics Inc |
Granular preparations for the administration of poorly soluble drugs
|
|
HRP20191104T1
(hr)
|
2007-09-25 |
2019-09-20 |
Solubest Ltd. |
Pripravci koji sadrže lipofilne aktivne spojeve i postupak za njihovu pripremu
|
|
EP2067471B1
(en)
|
2007-12-06 |
2018-02-14 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
FR2926996B1
(fr)
|
2008-01-31 |
2013-06-21 |
Ethypharm Sa |
Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine
|
|
EP2254559B1
(en)
|
2008-02-08 |
2018-10-10 |
Foresee Pharmaceuticals Co., Ltd. |
Composition for sustained release delivery of proteins or peptides
|
|
WO2009100222A1
(en)
|
2008-02-08 |
2009-08-13 |
Qps Llc |
Non-polymeric compositions for controlled drug delivery
|
|
JP5286850B2
(ja)
|
2008-03-14 |
2013-09-11 |
大日本印刷株式会社 |
液体用紙容器用包装材料およびその包装材料から製造される液体用紙容器
|
|
CA2718943A1
(en)
|
2008-03-26 |
2009-10-01 |
Alltranz Inc. |
Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
|
|
US8877225B2
(en)
|
2008-06-03 |
2014-11-04 |
Tolmar Therapeutics, Inc. |
Controlled release copolymer formulation with improved release kinetics
|
|
DK2291174T3
(en)
|
2008-06-03 |
2015-03-09 |
Tolmar Therapeutics Inc |
Liquid compositions comprising biocompatible oligomer-polymer compositions
|
|
US8128951B2
(en)
|
2008-09-15 |
2012-03-06 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
US8257722B2
(en)
|
2008-09-15 |
2012-09-04 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
US8114429B2
(en)
|
2008-09-15 |
2012-02-14 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
CA2756879A1
(en)
|
2009-04-23 |
2010-10-28 |
Londonpharma Ltd. |
Sublingual pharmaceutical composition comprising a neutral oil
|
|
RU2567032C2
(ru)
|
2009-05-01 |
2015-10-27 |
Апталис Фарматек, Инк. |
Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков
|
|
AU2010265213B2
(en)
|
2009-06-24 |
2012-08-23 |
Egalet Ltd. |
Controlled release formulations
|
|
FR2949061B1
(fr)
|
2009-08-12 |
2013-04-19 |
Debregeas Et Associes Pharma |
Microgranules flottants
|
|
CA2780645C
(en)
|
2009-11-18 |
2018-01-16 |
Nektar Therapeutics |
Salt form of a multi-arm polymer-drug conjugate
|
|
US20130023553A1
(en)
|
2010-01-12 |
2013-01-24 |
Nektar Therapeutics |
Pegylated opioids with low potential for abuse and side effects
|
|
BR112012023303A2
(pt)
|
2010-03-15 |
2020-08-25 |
Ipsen Pharma S.A.S. |
composição farmacêutica de ligantes do receptor do secretagogo do hormônio de crescimento.
|
|
US20110230816A1
(en)
|
2010-03-18 |
2011-09-22 |
Tyco Healthcare Group Lp |
Gels for Transdermal Delivery
|
|
EP2394664B1
(en)
|
2010-05-31 |
2016-06-01 |
Laboratorios Farmaceuticos Rovi, S.A. |
Antipsychotic injectable depot composition
|
|
EP2529756B1
(en)
|
2011-05-31 |
2021-05-19 |
Laboratorios Farmaceuticos Rovi, S.A. |
Risperidone and/or Paliperidone implant formulation
|
|
SI2394663T1
(sl)
|
2010-05-31 |
2022-02-28 |
Laboratorios Farmaceuticos Rovi, S.A. |
Sestave za injicirane biološko razgradljive vsadke in situ
|
|
WO2011161531A1
(en)
|
2010-06-24 |
2011-12-29 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition containing goserelin for in-situ implant
|
|
ME02367B
(me)
|
2010-09-21 |
2016-06-20 |
Purdue Pharma Lp |
Analozi buprenorfina kao agonisti i/ili antagonisti opioidnog receptora
|
|
CA2815898C
(en)
|
2010-11-17 |
2018-12-18 |
Hexal Ag |
Transdermal therapeutic system comprising buprenorphine
|
|
CN105748402B
(zh)
|
2010-11-24 |
2022-06-03 |
杜雷科特公司 |
生物可降解的药物递送组合物
|
|
US20140023692A1
(en)
|
2010-11-26 |
2014-01-23 |
Lisa Claire Du Toit |
Drug delivery device
|
|
EA201491164A1
(ru)
|
2011-12-12 |
2014-10-30 |
ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ |
Трансдермальная система доставки
|
|
US9468599B2
(en)
|
2011-12-27 |
2016-10-18 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US20140134261A1
(en)
|
2012-08-21 |
2014-05-15 |
Trinity Laboratories, Inc. |
Pharmaceutical Compositions Comprising Capsaicin Esters for Treating Pain and Cold Sores
|
|
RU2513514C1
(ru)
|
2012-11-23 |
2014-04-20 |
Общество с ограниченной ответственностью "НПК "Трифарма" |
Фармацевтическая композиция, содержащая налбуфина гидрохлорид, ее применение для лечения болевого синдрома средней и высокой интенсивности и способ получения фармацевтической композиции
|
|
CN103142458B
(zh)
|
2013-01-22 |
2015-09-09 |
莱普德制药有限公司 |
无成瘾性镇痛缓释递药系统的组方与制备方法
|
|
WO2014164754A1
(en)
|
2013-03-11 |
2014-10-09 |
Durect Corporation |
Injectable controlled release composition comprising high viscosity liquid carrier
|
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
|
US9393211B2
(en)
|
2013-03-15 |
2016-07-19 |
Oakwood Laboratories LLC |
High drug load buprenorphine microspheres and method of producing same
|
|
US20160303038A1
(en)
|
2013-11-21 |
2016-10-20 |
Pawar Harshal Ashok |
Oral films
|
|
US10525171B2
(en)
|
2014-01-24 |
2020-01-07 |
The Spectranetics Corporation |
Coatings for medical devices
|